000			02046 a2200625 4500
005			20250516225545.0
264		0	_c20150401
008			201504s 0 0 eng d
022			_a1476-5454
024	7		_a10.1038/eye.2014.172 _2doi
040			_aNLM _beng _cNLM
100	1		_aChen, Y-H
245	0	0	_aRefractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. _h[electronic resource]
260			_bEye (London, England) _cSep 2014
300			_a1080-6; quiz 1087 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAxial Length, Eye _xpathology
650	0	4	_aBevacizumab
650	0	4	_aChild, Preschool
650	0	4	_aCombined Modality Therapy
650	0	4	_aEmmetropia _xphysiology
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGestational Age
650	0	4	_aHumans
650	0	4	_aInfant, Very Low Birth Weight
650	0	4	_aIntravitreal Injections
650	0	4	_aLaser Coagulation
650	0	4	_aMale
650	0	4	_aMyopia _xepidemiology
650	0	4	_aPrevalence
650	0	4	_aRefraction, Ocular _xphysiology
650	0	4	_aRetinopathy of Prematurity _xdrug therapy
650	0	4	_aRetrospective Studies
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVisual Acuity _xphysiology
650	0	4	_aVitrectomy
700	1		_aChen, S-N
700	1		_aLien, R-I
700	1		_aShih, C-P
700	1		_aChao, A-N
700	1		_aChen, K-J
700	1		_aHwang, Y-S
700	1		_aWang, N-K
700	1		_aChen, Y-P
700	1		_aLee, K-H
700	1		_aChuang, C-C
700	1		_aChen, T-L
700	1		_aLai, C-C
700	1		_aWu, W-C
773	0		_tEye (London, England) _gvol. 28 _gno. 9 _gp. 1080-6; quiz 1087
856	4	0	_uhttps://doi.org/10.1038/eye.2014.172 _zAvailable from publisher's website
999			_c24081182 _d24081182